PGProcter & Gamble Co.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $2.00Beat
- vs $1.89 expected on Oct 22
- Stock move on it
- +5.58%
- one session
- Typical move
- ±3.7%
- average over 2 reports
- Price
- $168.10
- +0.26% today · $340B cap
Past and upcoming reports
2
| Oct 22, 2026 | Sep 30, 2026 | Time not given | $1.89 | Beat$2.00 | +5.58% |
| Jul 29, 2026 | Jun 30, 2026 | Time not given | $1.42 | $1.43 | −1.87% |
After the report
Jul 29, 2026 report
This covers the Jul 29, 2026 report. The Oct 22, 2026 numbers are in the table above.
PG beats Q4 EPS but growth concerns weigh on stock
Procter & Gamble reported fiscal Q4 EPS of $1.43, beating the $1.41 consensus by 1.6%. Despite the beat, the stock fell 1.5% on the following day as management's forward guidance for fiscal 2027 revenue and margins highlighted growth deceleration. The market focused on weak revenue growth (TTM +3.3% vs sector +6.0%) and subdued EPS growth forecasts (+3.2% 5Y), overshadowing strong quality metrics (ROE 31%, operating margin 24%).
Reported against expected
PG reported EPS of $1.43, beating the $1.41 consensus by 1.6%.
Guidance
Management's forward guidance for fiscal 2027 revenue and margins highlighted growth concerns, overshadowing the beat.
How the stock reacted
Stock fell 1.5% on the day following the report, closing at $143.95.
What changed
PG beat EPS by 1.6% but guided cautiously on FY2027 growth.
What the price now assumes
Stock decline signals market pricing in growth deceleration despite a quality beat.
What it means for the business
Upgrade bias limited. watch FY2027 revenue guidance for inflection.
The next one to three months, as we saw it then
Better case20%
Consumer spending stabilizes and PG's pricing power drives revenue acceleration above 4% in FY2027, validating the quality premium.
Base case50%
PG delivers in-line FY2027 revenue growth of 2-3% with stable margins. stock trades in a $140-$150 range.
Worse case30%
Growth concerns persist as revenue decelerates below 2%, compressing the PEG ratio and eroding the quality premium.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.